Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss
Conditions
Interventions
500 mL/day of a beverage providing approximately 625 mg catechins
Control beverage matched for energy and caffeine content
Locations
2
United States
Meridien Research
St. Petersburg, Florida, United States
Provident Clinical Research
Bloomington, Indiana, United States
Start Date
June 1, 2006
Primary Completion Date
July 1, 2007
Completion Date
August 1, 2007
Last Updated
June 6, 2008
NCT07472881
NCT01143454
NCT07010757
NCT06989203
NCT06223555
NCT07237750
Lead Sponsor
Provident Clinical Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions